BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Bismuth Subsalicylate, Metronidazole And Tetracycline Hydrochloride patents expire, and what generic alternatives are available?
Bismuth Subsalicylate, Metronidazole And Tetracycline Hydrochloride is a drug marketed by Nostrum Labs Inc and is included in one NDA.
The generic ingredient in BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE is bismuth subsalicylate; metronidazole; tetracycline hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the bismuth subsalicylate; metronidazole; tetracycline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE?
- What are the global sales for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE?
- What is Average Wholesale Price for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE?
Summary for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 2 |
| DailyMed Link: | BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| National Cancer Institute (NCI) | Phase 2 |
See all BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE clinical trials
US Patents and Regulatory Information for BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs Inc | BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | bismuth subsalicylate; metronidazole; tetracycline hydrochloride | TABLET, CHEWABLE, TABLET, CAPSULE;ORAL | 202584-001 | Nov 30, 2018 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
